The Metabolic Score for Insulin Resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic Fatty Liver Disease in Hyperuricemia Subjects

References

• Younossi Z, Tacke F, Arrese M, et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 2019;69(6):2672–2682. doi:10.1002/hep.30251
   PubMed Web of Science ®Google Scholar
• Yang C, Yang S, Xu W, Zhang J, Fu W, Feng C. Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: a retrospective cohort study. PLoS One. 2017;12(5):e0177249. doi:10.1371/journal.pone.0177249
   PubMed Web of Science ®Google Scholar
• Zhou F, Zhou J, Wang W, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a Systematic review and meta-analysis. Hepatology. 2019;70(4):1119–1133. doi:10.1002/hep.30702
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–2023. doi:10.1002/hep.25762
   PubMed Web of Science ®Google Scholar
• Yang C, He Q, Chen Z, et al. A bidirectional relationship between hyperuricemia and metabolic dysfunction-associated fatty liver disease. Front Endocrinol. 2022;13:821689. doi:10.3389/fendo.2022.821689
   PubMed Web of Science ®Google Scholar
• Duell PB, Welty FK, Miller M, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42(6):e168–e185. doi:10.1161/ATV.0000000000000153
   PubMed Web of Science ®Google Scholar
• Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology. 2005;20:125–133.
   PubMed Web of Science ®Google Scholar
• Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22(17):9221. doi:10.3390/ijms22179221
   PubMed Web of Science ®Google Scholar
• Helget LN, Mikuls TR. Environmental triggers of hyperuricemia and gout. Rheum Dis Clin North Am. 2022;48(4):891–906. doi:10.1016/j.rdc.2022.06.009
   PubMed Web of Science ®Google Scholar
• Wang J, Qin T, Chen J, et al. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One. 2014;9(12):e114259. doi:10.1371/journal.pone.0114259
   PubMed Web of Science ®Google Scholar
• Peng L-H, He Y, Xu W-D, et al. Carotid intima-media thickness in patients with hyperuricemia: a systematic review and meta-analysis. Aging Clin Exp Res. 2021;33(11):2967–2977. doi:10.1007/s40520-021-01850-x
   PubMed Web of Science ®Google Scholar
• Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol. 2009;50(5):1029–1034. doi:10.1016/j.jhep.2008.11.021
   PubMed Web of Science ®Google Scholar
• Wan X, Xu C, Lin Y, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925–932. doi:10.1016/j.jhep.2015.11.022
   PubMed Web of Science ®Google Scholar
• Choi Y-J, Shin H-S, Choi HS, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest. 2014;94(10):1114–1125. doi:10.1038/labinvest.2014.98
   PubMed Web of Science ®Google Scholar
• Li X, Huang W, Gu J, et al. SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver. Cell Signal. 2015;27(10):2099–2109. doi:10.1016/j.cellsig.2015.07.011
   PubMed Web of Science ®Google Scholar
• Xu C. Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back. Hepatol Internat. 2016;10(2):286–293. doi:10.1007/s12072-015-9682-5
   PubMed Web of Science ®Google Scholar
• Wang F-S, Fan J-G, Zhang Z, Gao B, Wang H-Y. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099–2108. doi:10.1002/hep.27406
   PubMed Web of Science ®Google Scholar
• Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–544. doi:10.1530/EJE-17-0883
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi:10.1089/met.2008.0034
   PubMedGoogle Scholar
• Liu XZ, Fan J, Pan SJ. METS-IR, a novel simple insulin resistance indexes, is associated with hypertension in normal-weight Chinese adults. J Clin Hypertens. 2019;21(8):1075–1081. doi:10.1111/jch.13591
   Web of Science ®Google Scholar
• Tao L-C, J-N X, Wang -T-T, Hua F, Li -J-J. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68. doi:10.1186/s12933-022-01511-x
   PubMed Web of Science ®Google Scholar
• Petrescu M, Vlaicu SI, Ciumărnean L, et al. Chronic inflammation-a link between Nonalcoholic Fatty Liver Disease (NAFLD) and dysfunctional adipose tissue. Medicina. 2022;58(5):641. doi:10.3390/medicina58050641
   PubMedGoogle Scholar
• Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297–302. doi:10.1080/00325481.2022.2039007
   PubMed Web of Science ®Google Scholar
• Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021;59(4):403–408. doi:10.2478/rjim-2021-0023
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 2019;65(1). doi:10.1590/1806-9282.65.1.9
   Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–1102. doi:10.1080/13685538.2019.1678126
   PubMed Web of Science ®Google Scholar
• Zhou C, Liu M, Zhang Z, et al. Positive association of serum uric acid with new-onset diabetes in Chinese women with hypertension in a retrospective analysis of the China Stroke Primary Prevention Trial. Diabetes Obes Metab. 2020;22(9):1598–1606. doi:10.1111/dom.14072
   PubMed Web of Science ®Google Scholar
• Aktas G, Yilmaz S, Kantarci DB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519–523. doi:10.1080/00325481.2023.2214058
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 2021;67(4):549–554. doi:10.1590/1806-9282.20201005
   PubMed Web of Science ®Google Scholar
• van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate Imputation by Chained Equations in R. Journal of Statistical Software. 2011;45(3):1–67. doi:10.18637/jss.v045.i03
   Web of Science ®Google Scholar
• Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264–1281.e4.
   PubMed Web of Science ®Google Scholar
• Huang X, He J, Wu G, Peng Z, Yang B, Ye L. TyG-BMI and hypertension in Normoglycemia subjects in Japan: a cross-sectional study. Diab Vasc Dis Res. 2023;20(3):14791641231173617. doi:10.1177/14791641231173617
   Web of Science ®Google Scholar
• Akin F, Altun İ, Ayca B, Kose N, Altun İ. Associations of non-HDL-C and triglyceride/HDL-C ratio with coronary plaque burden and plaque characteristics in young adults. Bosn J Basic Med Sci. 2022;22(6):1025–1032. doi:10.17305/bjbms.2022.7142
   PubMed Web of Science ®Google Scholar
• Al Akl NS, Haoudi EN, Bensmail H, Arredouani A. The triglyceride glucose-waist-to-height ratio outperforms obesity and other triglyceride-related parameters in detecting prediabetes in normal-weight Qatari adults: a cross-sectional study. Front Public Health. 2023;11:1086771. doi:10.3389/fpubh.2023.1086771
   PubMed Web of Science ®Google Scholar
• Zhang S, Du T, Zhang J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15. doi:10.1186/s12944-017-0409-6
   PubMedGoogle Scholar
• Song K, Lee HW, Choi HS, et al. Comparison of the modified TyG indices and other parameters to predict non-alcoholic fatty liver disease in youth. Biology. 2022;11(5):685. doi:10.3390/biology11050685
   PubMedGoogle Scholar
• Smiderle CA, Coral GP, De Carli LA, Mattos AAD, Mattos AZD, Tovo CV. Performace of triglyceride-glucose index on diagnosis and staging of nafld in obese patients. Arq Gastroenterol. 2021;58(2):139–144. doi:10.1590/S0004-2803.202100000-24
   PubMedGoogle Scholar
• Widjaja NA, Irawan R, Hanindita MH, Ugrasena I, Handajani R. METS-IR vs. HOMA-AD and metabolic syndrome in obese adolescents. J Med Invest. 2023;70(1.2):7–16.
   PubMed Web of Science ®Google Scholar
• Lee J-H, Park K, Lee HS, Park H-K, Han JH, Ahn SB. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Clin Mol Hepatol. 2022;28(4):814–826. doi:10.3350/cmh.2022.0099
   PubMed Web of Science ®Google Scholar
• Han T, Lan L, Qu R, et al. Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension. Hypertension. 2017;70(4):703–711. doi:10.1161/HYPERTENSIONAHA.117.09508
   PubMed Web of Science ®Google Scholar
• Mazidi M, Katsiki N, Mikhailidis DP, Banach M. The link between insulin resistance parameters and serum uric acid is mediated by adiposity. Atherosclerosis. 2018;270:180–186. doi:10.1016/j.atherosclerosis.2017.12.033
   PubMed Web of Science ®Google Scholar
• Gastaldelli A. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD? Clin Sci. 2017;131(22):2701–2704. doi:10.1042/CS20170987
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhu X, Wu J, et al. Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015–16 and 2018–19. Front Immunol. 2021;12:791983. doi:10.3389/fimmu.2021.791983
   PubMed Web of Science ®Google Scholar
• Chen Z, Qin H, Qiu S, Chen G, Chen Y. Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research. Lipids Health Dis. 2019;18(1):162. doi:10.1186/s12944-019-1104-6
   PubMed Web of Science ®Google Scholar
• Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2017;23(47):8263–8276. doi:10.3748/wjg.v23.i47.8263
   PubMed Web of Science ®Google Scholar
• Yen P-C, Chou Y-T, Li C-H, et al. Hyperuricemia is associated with significant liver fibrosis in subjects with nonalcoholic fatty liver disease, but not in subjects without it. J Clin Med. 2022;11(5):1445. doi:10.3390/jcm11051445
   PubMed Web of Science ®Google Scholar